How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,625 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy? (Abstract)

Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy? The aims of this study were to compare three different interventions to reduce pain related to insertion of the intrauterine device (IUD), namely, lidocaine, misoprostol and a non-steroidal anti-inflammatory drug, against a placebo, and to assess the advantages of one drug over another, if any.This was an open-label randomised placebo-controlled trial of 200 women assigned to receive one (...) participants in each group). All characteristics were similar between the groups. The mean pain scores recorded during speculum placement, tenaculum application, uterine sounding, IUD insertion and 15 min after insertion were similar among the four groups (p > .05). Adjuvant methods to facilitate insertion, insertion failure or device expulsion were similar between the groups (p > .05). Complications were reported in 17 participants (8.5%); all resolved spontaneously with no further management (p > .05

2018 The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception Controlled trial quality: predicted high

62. One year continuation of post-partum intrauterine contraceptive device: findings from a retrospective cohort study in India. Full Text available with Trip Pro

One year continuation of post-partum intrauterine contraceptive device: findings from a retrospective cohort study in India. To evaluate outcomes of a national postpartum (within 48 h of delivery) copper intrauterine device placement (PPCuIUD) program in six "high-focus states" with high unmet family planning need in India.We identified high-volume district hospitals that provided PPCuIUD in six (Bihar, Jharkhand, Uttar Pradesh, Uttarakhand, Madhya Pradesh and Chhattisgarh) Indian states (two

2018 Contraception

63. Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices. Full Text available with Trip Pro

Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices. Candida biofilm infections are frequently linked to the use of biomaterials and are of clinical significance because they are commonly resistant to antifungals. Clioquinol is an antiseptic drug and is effective against multidrug-resistant Candida. We investigated the effect of clioquinol and two other 8-hydroxyquinoline derivatives on Candida (...) biofilm.The ability to inhibit biofilm formation, inhibit preformed biofilm and remove established biofilms was evaluated using in vitro assays on microtitre plates. The action of clioquinol on biofilm in intrauterine devices (IUDs) was also investigated, describing the first protocol to quantify the inhibitory action of compounds on biofilms formed on IUDs.Clioquinol was found to be the most effective 8-hydroxyquinoline derivative among those tested. It prevented more than 90 % of biofilm formation

2018 Journal of Medical Microbiology

64. Effect of Baseline Menstrual Bleeding Pattern on Copper Intrauterine Device Continuation. Full Text available with Trip Pro

Effect of Baseline Menstrual Bleeding Pattern on Copper Intrauterine Device Continuation. Heavy menstrual bleeding is a leading cause of copper intrauterine device discontinuation. Thus, girls and women with heavy baseline menstrual bleeding may be at increased risk for early copper intrauterine device discontinuation.Our objective was to assess if there was an association between baseline menstrual bleeding pattern prior to intrauterine device insertion and discontinuation rate at 12 months (...) among study participants who chose copper intrauterine device at baseline.We performed a secondary analysis of the Contraceptive CHOICE Project, a prospective observational cohort study of 9256 girls and women offered no-cost contraception for 2-3 years. Included in our study were participants who chose copper intrauterine device for contraception and for whom method continuation data at 12 months were available. Prior to contraception initiation, participants were asked to qualify their menstrual

2018 American Journal of Obstetrics and Gynecology

65. Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method

Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method (KIDDS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier

2018 Clinical Trials

66. Surveillance Study of the Contraceptive Intrauterine Device UT380®

Surveillance Study of the Contraceptive Intrauterine Device UT380® Surveillance Study of the Contraceptive Intrauterine Device UT380® - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Surveillance Study (...) of the Contraceptive Intrauterine Device UT380® (CCDDIUUT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03642171 Recruitment Status : Recruiting First Posted : August 22, 2018 Last Update Posted : September 3, 2018 See Sponsor

2018 Clinical Trials

67. Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques

Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03724708 Recruitment Status : Recruiting First Posted : October 30, 2018 Last Update

2018 Clinical Trials

68. Immediate Postpartum Insertion of Contraceptive Intrauterine Devices

Immediate Postpartum Insertion of Contraceptive Intrauterine Devices Immediate Postpartum Insertion of Contraceptive Intrauterine Devices - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Immediate Postpartum (...) Insertion of Contraceptive Intrauterine Devices The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03657602 Recruitment Status : Not yet recruiting First Posted : September 5, 2018 Last Update Posted : January 25, 2019 See

2018 Clinical Trials

69. Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.

Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03686085

2018 Clinical Trials

70. Steroid reservoir loss during removal of perforated Levonorgestrel 52mg intrauterine device. (Abstract)

Steroid reservoir loss during removal of perforated Levonorgestrel 52mg intrauterine device. A 22-year-old G1P1 Caucasian female had hysteroscopic removal of a perforated intrauterine device during which the steroid reservoir of the intrauterine device was lost. Isolated steroid reservoirs are radiolucent on plain film radiography. We located the reservoir in the peritoneal cavity with magnetic resonance imaging and removed it via laparoscopy.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 Contraception

71. A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion. Full Text available with Trip Pro

A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion. To compare, using decision analysis methodology, the 1-year probability of pregnancy after intended postplacental intrauterine device (IUD) insertion with intended delayed insertion at an outpatient postpartum visit (delayed postpartum placement).We developed an evidence-based decision model with the primary outcome of 1-year probability

2018 Obstetrics and Gynecology

72. Experience with Intrauterine Device Insertion in Never Sexually Active Adolescents: A Retrospective Cohort Study. (Abstract)

Experience with Intrauterine Device Insertion in Never Sexually Active Adolescents: A Retrospective Cohort Study. Intrauterine devices can offer both contraceptive and noncontraceptive benefits to never sexually active adolescents. There are increasing data on intrauterine device use in adolescents; however, most data on intrauterine devices in adolescents are related to contraceptive use. There is very limited literature on intrauterine device placement in adolescents who have never been (...) sexually active.The objective of the study was to compare intrauterine device insertion success between never sexually active and sexually active cohorts.We performed a retrospective chart review of patients aged 10-20 years with attempted intrauterine device insertion at a children's hospital between October 2015 and September 2017.A total of 210 patients were included, of whom 82 were never sexually active. Never sexually active adolescents were younger at insertion (15.6 vs 16.7 years, P < .001

2018 American Journal of Obstetrics and Gynecology

73. The Management of a Patient with a fragmented intrauterine device embedded within the Cervical Canal. (Abstract)

The Management of a Patient with a fragmented intrauterine device embedded within the Cervical Canal. A 28-year-old woman presented with a malpositioned intrauterine device (IUD) that was fragmented and significantly entrenched within the cervical canal and myometrium. IUD malposition with concomitant device fragmentation and embedded segments, albeit rare, should be a consideration given the device's prevalence.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 Contraception

74. Effect of Motivational Interviewing on Using Intrauterine Device in Women at High Risk for Pregnancy Full Text available with Trip Pro

Effect of Motivational Interviewing on Using Intrauterine Device in Women at High Risk for Pregnancy Reproductive health programs help women live healthier. Family planning consultation is an important component of reproductive health. A good family planning consultation can increase the use of effective birth control methods and improve the life quality of people, specifically of those at high risk. One of the most effective birth control techniques is an intrauterine device (IUD).This study

2018 Open access Macedonian journal of medical sciences Controlled trial quality: uncertain

75. Postpartum intrauterine device placement: a patient-friendly option Full Text available with Trip Pro

Postpartum intrauterine device placement: a patient-friendly option Women in the United States are increasingly choosing an intrauterine device (IUD) for contraception. Since the postpartum period is an important time to consider a patient's need for contraception, offering postpartum IUD placement is considered best practice. Effective implementation of postpartum IUD placement occurs within a context of shared decision making wherein patients are given full information about all options

2018 Contraception and Reproductive Medicine

76. Adhesion and biofilm formation of Candida parapsilosis isolated from vaginal secretions to copper intrauterine devices Full Text available with Trip Pro

Adhesion and biofilm formation of Candida parapsilosis isolated from vaginal secretions to copper intrauterine devices Candida parapsilosis is one of the main species that is able to adhere to forming biofilms on inert materials. Adhesion is the first step towards the colonization and invasion of host cells during the infectious process. Among the infections, vulvovaginal candidiasis is increasingly common. The objective was to evaluate the profile of adherence and biofilm formation of eight (...) isolates of C. parapsilosis on the metal used in intrauterine devices (IUDs).Eight strains of C. parapsilosis presenting strong adhesion and biofilm formation properties were isolated from vaginal secretions in a previous study. To assay the adhesion and biofilm formation, copper fragments were made and cultivated in tubes containing 3 mL of phosphate-buffered saline and incubated for 6 and 24 h at 37 °C to evaluate biofilm formation. After incubation, the intensity of adherence and of biofilm

2018 Revista do Instituto de Medicina Tropical de São Paulo

77. Colonoscopic Removal of an Intrauterine Device That Had Perforated the Rectosigmoid Colon Full Text available with Trip Pro

Colonoscopic Removal of an Intrauterine Device That Had Perforated the Rectosigmoid Colon The intrauterine device (IUD) is a widely used contraceptive method. One of the most serious and rare complications of using an IUD is colon perforation. We report a case of colonoscopic removal of an IUD that had perforated into the rectosigmoid colon in a 42-year-old woman who presented with no symptoms. Colonoscopy showed that the IUD had penetrated into rectosigmoid colon wall and that an arm

2018 Annals of coloproctology

78. Hysteroscopic-guided Removal of Retained Intrauterine Device: Experience at an Academic Tertiary Hospital Full Text available with Trip Pro

Hysteroscopic-guided Removal of Retained Intrauterine Device: Experience at an Academic Tertiary Hospital Removal of an intrauterine device can be easily done when the string is visible during speculum exam. The task becomes challenging when the string is no longer visible.The in-patient and out-patient medical records of all patients admitted for hysteroscopic-guided intrauterine device removal from January 2013 to December 2015 from a tertiary academic government hospital were retrieved

2018 Gynecology and Minimally Invasive Therapy

79. Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study Full Text available with Trip Pro

Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study This pilot study assessed the feasibility of conducting a larger randomized controlled trial comparing the proportion of adolescents using a levonorgestrel intrauterine device (LNG IUD) at six months postpartum when it is inserted immediately after vaginal delivery (within 10 minutes after placental expulsion) compared to insertion four to six weeks postpartum

2018 Hawai'i Journal of Medicine & Public Health Controlled trial quality: uncertain

80. Hydronephrosis due to a Migrated Intrauterine Device into the Ureter: A Very Rare Case Full Text available with Trip Pro

Hydronephrosis due to a Migrated Intrauterine Device into the Ureter: A Very Rare Case Intrauterine device (IUD) insertion is a long-acting and one of the most effective modes of reversible contraception. Complications that most commonly arise following IUD insertion are failed insertion, pain, vasovagal reactions, infection, menstrual abnormalities, and expulsion. In this paper, we present the case of a woman who experienced hydronephrosis due to the migration of IUD into the ureter after 30

2018 The Eurasian journal of medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>